7-Methylguanosine

CAS No. 20244-86-4

7-Methylguanosine( —— )

Catalog No. M20660 CAS No. 20244-86-4

7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor (IC50 : 87.8?±?7.5?μM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 27 In Stock
50MG 77 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    7-Methylguanosine
  • Note
    Research use only, not for human use.
  • Brief Description
    7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor (IC50 : 87.8?±?7.5?μM).
  • Description
    7-Methylguanosine is a novel cNIIIB nucleotidase inhibitor (IC50 : 87.8?±?7.5?μM).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Nucleoside Antimetabolite/Analog
  • Recptor
    cNIIIB nucleotidase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    20244-86-4
  • Formula Weight
    298.27
  • Molecular Formula
    C11H16N5O5+
  • Purity
    >98% (HPLC)
  • Solubility
    H2O:83.33 mg/mL (279.38 mM; Need ultrasonic);DMSO:12.5 mg/mL (41.91 mM; Need ultrasonic)
  • SMILES
    C[n+]1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2nc(N)[nH]c(=O)c12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kozarski M Kubacka D Wojtczak B A et al. 7-Methylguanosine monophosphate analogues with 5'-(123-triazoyl) moiety: Synthesis and evaluation as the inhibitors of cNIIIB nucleotidase[J]. Bioorganic & Medicinal Chemistry 2018 26(1):191.
molnova catalog
related products
  • Sapacitabine

    An orally available, nucleoside analog prodrug of CNDAC that interferes with DNA synthesis by causing single-strand DNA breaks.

  • N2-Methylguanosine

    N2-methylguanosine is a modified nucleoside of tRNA that occurs at several specific locations in many tRNA's.

  • Cedazuridine

    Cedazuridine (E7727) is a novel cytidine deaminase inhibitor, and a componet of ASTX727 for treatment of hematologic malignancies.